Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway
2014 ◽
Dynamic FDG-PET/CT as an indicator of tumor aggressiveness and patient outcome in pancreatic cancer.
2010 ◽
Vol 28
(15_suppl)
◽
pp. e14526-e14526
2013 ◽
Vol 73
(17)
◽
pp. 5416-5425
◽
Keyword(s):